BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27429222)

  • 1. Evaluation and Management of Chemotherapy-Induced Epiphora, Punctal and Canalicular Stenosis, and Nasolacrimal Duct Obstruction.
    Mansur C; Pfeiffer ML; Esmaeli B
    Ophthalmic Plast Reconstr Surg; 2017; 33(1):9-12. PubMed ID: 27429222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockage of the lacrimal drainage apparatus as a side effect of docetaxel therapy.
    Esmaeli B; Hidaji L; Adinin RB; Faustina M; Coats C; Arbuckle R; Rivera E; Valero V; Tu SM; Ahmadi MA
    Cancer; 2003 Aug; 98(3):504-7. PubMed ID: 12879466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canalicular stenosis secondary to weekly versus every-3-weeks docetaxel in patients with metastatic breast cancer.
    Esmaeli B; Hortobagyi GN; Esteva FJ; Booser D; Ahmadi MA; Rivera E; Arbuckle R; Delpassand E; Guerra L; Valero V
    Ophthalmology; 2002 Jun; 109(6):1188-91. PubMed ID: 12045065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canalicular stenosis secondary to docetaxel (taxotere): a newly recognized side effect.
    Esmaeli B; Valero V; Ahmadi MA; Booser D
    Ophthalmology; 2001 May; 108(5):994-5. PubMed ID: 11320034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canalicular stenosis secondary to weekly docetaxel: a potentially preventable side effect.
    Esmaeli B; Hortobagyi G; Esteva F; Valero V; Ahmadi MA; Booser D; Ibrahim N; Delpassand E; Arbuckle R
    Ann Oncol; 2002 Feb; 13(2):218-21. PubMed ID: 11885997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of functional epiphora in patients with an anatomically patent dacryocystorhinostomy.
    Shams PN; Chen PG; Wormald PJ; Sloan B; Wilcsek G; McNab A; Selva D
    JAMA Ophthalmol; 2014 Sep; 132(9):1127-32. PubMed ID: 24903661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of incidence and severity of epiphora and canalicular stenosis in patients with metastatic breast cancer receiving docetaxel.
    Esmaeli B; Amin S; Valero V; Adinin R; Arbuckle R; Banay R; Do KA; Rivera E
    J Clin Oncol; 2006 Aug; 24(22):3619-22. PubMed ID: 16877729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical treatment of canalicular stenosis in patients receiving docetaxel weekly.
    Ahmadi MA; Esmaeli B
    Arch Ophthalmol; 2001 Dec; 119(12):1802-4. PubMed ID: 11735790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of epiphora in the presence of congenital punctal and canalicular atresia.
    Cahill KV; Burns JA
    Ophthalmic Plast Reconstr Surg; 1991; 7(3):167-72. PubMed ID: 1911521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of mini-monoka stents for punctal/canalicular stenosis.
    Hussain RN; Kanani H; McMullan T
    Br J Ophthalmol; 2012 May; 96(5):671-3. PubMed ID: 22241928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lacrimal and nasal masquerades of congenital nasolacrimal duct obstructions: etiology, management, and outcomes.
    Kamal S; Ali MJ; Gupta A; Naik MN
    Int Ophthalmol; 2015 Dec; 35(6):807-10. PubMed ID: 25680420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blind canalicular marsupialization in complete punctal absence as part of a systematic approach for classification and treatment of lacrimal system obstructions.
    Rumelt S
    Plast Reconstr Surg; 2003 Aug; 112(2):396-403. PubMed ID: 12900596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment of punctal-canalicular fibrosis from 5-fluorouracil therapy.
    Seiff SR; Shorr N; Adams T
    Cancer; 1985 Oct; 56(8):2148-9. PubMed ID: 4027942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of excessive tearing as a side effect of docetaxel.
    Esmaeli B
    Clin Breast Cancer; 2005 Feb; 5(6):455-7. PubMed ID: 15748466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epiphora (excessive tearing) and other ocular manifestations related to weekly docetaxel: underestimated dose-limiting toxicity.
    Tsalic M; Gilboa M; Visel B; Miller B; Haim N
    Med Oncol; 2006; 23(1):57-61. PubMed ID: 16645230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin for palliative treatment of epiphora in a patient with canalicular obstruction.
    Tu AH; Chang EL
    Ophthalmology; 2005 Aug; 112(8):1469-71. PubMed ID: 15953639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canalicular and nasolacrimal duct blockage: an ocular side effect associated with the antineoplastic drug S-1.
    Esmaeli B; Golio D; Lubecki L; Ajani J
    Am J Ophthalmol; 2005 Aug; 140(2):325-7. PubMed ID: 16086962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rare case of pemetrexed-induced diffuse punctal and canalicular stenosis: management by coronary balloon puncto-canaliculoplasty.
    Sharma A; Pattnaik M; Ali MJ
    Orbit; 2022 Dec; 41(6):763-765. PubMed ID: 33938345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epiphora in lung cancer patients receiving docetaxel: a case series.
    Yamagishi T; Ochi N; Yamane H; Hasebe S; Takigawa N
    BMC Res Notes; 2014 May; 7():322. PubMed ID: 24886618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epiphora and canalicular stenosis associated with adjuvant docetaxel in early breast cancer: is excessive tearing clinically important?
    Esmaeli B; Valero V
    J Clin Oncol; 2013 Jun; 31(17):2076-7. PubMed ID: 23650413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.